Skip to content
lifestyle.womensconference.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Longeveron
Longeveron Announces Topline Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel as a Potential Treatment for Hypoplastic Left Heart Syndrome (HLHS)
September 16, 2026
Longeveron to Present at the H.C. Wainwright 28th Annual Global Investment Conference
September 3, 2026
Longeveron Announces 1-for-10 Reverse Stock Split
August 24, 2026
Longeveron Appoints Nirav Jhaveri as Chief Financial Officer
August 19, 2026
Longeveron Announces 2026 Second Quarter Financial Results and Provides Business Update
August 12, 2026
Longeveron Named a Finalist Team and Will Receive a $1,000,000 Milestone 2 Award for the XPRIZE Healthspan Global Competition
August 11, 2026
Longeveron to Report 2026 Second Quarter Financial Results and Host Conference Call on August 12, 2026
August 3, 2026
Deborah D. Ascheim, M.D. Elected to Longeveron Board of Directors
July 23, 2026
Longeveron Announces Presentation of Clinical Data at the 2026 Alzheimer’s Association International Conference (AAIC) that Indicate Its Cellular Therapy Laromestrocel Reduced Neuroinflammation in Patients with Alzheimer’s Disease
July 13, 2026
Longeveron® Appoints Marie Washburn as Chief Financial Officer
July 6, 2026
1
2
3
Next Page
→